Benjamin F. Edwards & Company’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $44.5M | Buy |
359,791
+12,661
| +4% | +$1.63M | 0.78% | 22 |
|
|
2024
Q1 | $45.8M | Buy |
347,130
+12,964
| +4% | +$1.6M | 0.83% | 20 |
|
|
2023
Q4 | $36.4M | Buy |
334,166
+261,901
| +362% | +$27.2M | 0.73% | 28 |
|
|
2023
Q3 | $7.44M | Buy |
72,265
+22,522
| +45% | +$2.43M | 0.29% | 83 |
|
|
2023
Q2 | $5.74M | Buy |
49,743
+1,159
| +2% | +$132K | 0.22% | 97 |
|
|
2023
Q1 | $5.17M | Sell |
48,584
-477
| -1% | -$51.5K | 0.22% | 104 |
|
|
2022
Q4 | $5.44M | Sell |
49,061
-268
| -0.5% | -$27.4K | 0.24% | 97 |
|
|
2022
Q3 | $4.25M | Buy |
49,329
+649
| +1% | +$57.9K | 0.21% | 107 |
|
|
2022
Q2 | $4.44M | Buy |
48,680
+722
| +2% | +$64K | 0.21% | 113 |
|
|
2022
Q1 | $3.94M | Sell |
47,958
-63
| -0.1% | -$4.97K | 0.18% | 130 |
|
|
2021
Q4 | $3.68M | Buy |
48,021
+6,658
| +16% | +$530K | 0.16% | 142 |
|
|
2021
Q3 | $3.11M | Buy |
41,363
+3,921
| +10% | +$298K | 0.16% | 145 |
|
|
2021
Q2 | $2.91M | Sell |
37,442
-15,152
| -29% | -$1.13M | 0.15% | 158 |
|
|
2021
Q1 | $3.87M | Buy |
52,594
+4,688
| +10% | +$346K | 0.21% | 120 |
|
|
2020
Q4 | $3.74M | Buy |
47,906
+918
| +2% | +$70.2K | 0.22% | 110 |
|
|
2020
Q3 | $3.72M | Buy |
46,988
+640
| +1% | +$50.1K | 0.25% | 96 |
|
|
2020
Q2 | $3.42M | Sell |
46,348
-3,420
| -7% | -$257K | 0.25% | 101 |
|
|
2020
Q1 | $3.65M | Buy |
49,768
+2,111
| +4% | +$166K | 0.31% | 83 |
|
|
2019
Q4 | $4.14M | Buy |
47,657
+7,511
| +19% | +$617K | 0.29% | 87 |
|
|
2019
Q3 | $3.23M | Sell |
40,146
-1,544
| -4% | -$124K | 0.25% | 102 |
|
|
2019
Q2 | $3.34M | Buy |
41,690
+5,512
| +15% | +$422K | 0.28% | 88 |
|
|
2019
Q1 | $2.87M | Sell |
36,178
-378
| -1% | -$28.3K | 0.26% | 94 |
|
|
2018
Q4 | $2.67M | Buy |
36,556
+2,358
| +7% | +$166K | 0.28% | 83 |
|
|
2018
Q3 | $2.31M | Buy |
34,198
+1,424
| +4% | +$90.7K | 0.22% | 111 |
|
|
2018
Q2 | $1.9M | Sell |
32,774
-3,174
| -9% | -$179K | 0.19% | 125 |
|
|
2018
Q1 | $1.87M | Buy |
35,948
+8,387
| +30% | +$453K | 0.19% | 121 |
|
|
2017
Q4 | $1.48M | Buy |
27,561
+4,425
| +19% | +$245K | 0.15% | 152 |
|
|
2017
Q3 | $1.41M | Sell |
23,136
-2
| -0% | -$121 | 0.17% | 131 |
|
|
2017
Q2 | $1.42M | Buy |
23,138
+45
| +0.2% | +$2.74K | 0.18% | 123 |
|
|
2017
Q1 | $1.4M | Buy |
23,093
+953
| +4% | +$57.8K | 0.21% | 109 |
|
|
2016
Q4 | $1.24M | Buy |
22,140
+1,277
| +6% | +$74.7K | 0.2% | 119 |
|
|
2016
Q3 | $1.24M | Buy |
20,863
+4,527
| +28% | +$265K | 0.22% | 103 |
|
|
2016
Q2 | $898K | Sell |
16,336
-176
| -1% | -$9.37K | 0.18% | 129 |
|
|
2016
Q1 | $834K | Buy |
16,512
+361
| +2% | +$17.7K | 0.17% | 131 |
|
|
2015
Q4 | $814K | Sell |
16,151
-782
| -5% | -$39.4K | 0.18% | 131 |
|
|
2015
Q3 | $798K | Sell |
16,933
-25,368
| -60% | -$1.35M | 0.17% | 127 |
|
|
2015
Q2 | $2.3M | Sell |
42,301
-763
| -2% | -$42.8K | 0.46% | 47 |
|
|
2015
Q1 | $2.36M | Buy |
43,064
+2,191
| +5% | +$124K | 0.5% | 47 |
|
|
2014
Q4 | $2.21M | Sell |
40,873
-222
| -0.5% | -$12.4K | 0.51% | 41 |
|
|
2014
Q3 | $2.33M | Sell |
41,095
-332
| -0.8% | -$18.6K | 0.58% | 40 |
|
|
2014
Q2 | $2.29M | Buy |
41,427
+655
| +2% | +$35.7K | 0.58% | 38 |
|
|
2014
Q1 | $2.21M | Buy |
40,772
+5,179
| +15% | +$268K | 0.61% | 35 |
|
|
2013
Q4 | $1.7M | Sell |
35,593
-496
| -1% | -$22.7K | 0.57% | 41 |
|
|
2013
Q3 | $1.64M | Buy |
36,089
+609
| +2% | +$27.8K | 0.61% | 41 |
|
|
2013
Q2 | $1.57M | Buy |
+35,480
| New | +$1.58M | 0.63% | 41 |
|
Other funds holding MRK
Benjamin F. Edwards & Company's MRK Position: Q2 2024 in Review
Benjamin F. Edwards & Company increased its Merck (MRK) stake by 3.6% in Q2 2024, buying an estimated $1.63M and bringing the position to 359,791 shares worth $44.5M. The position accounts for 0.78% of the portfolio, ranked #22.
Benjamin F. Edwards & Company first reported a position in MRK in Q2 2013 and has held it in 45 quarters since. The position peaked at $45.8M in Q1 2024. 3,545 funds tracked by Wall St. Rank hold MRK as of Q2 2024.
- Benjamin F. Edwards & Company held 359,791 shares of Merck worth $44.5M as of Q2 2024.
- Benjamin F. Edwards & Company bought 12,661 Merck shares in Q2 2024, an estimated $1.63M.
- Merck made up 0.78% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #22 holding.
- Benjamin F. Edwards & Company first reported a position in Merck in Q2 2013 and has held it in 45 quarters since.
- Benjamin F. Edwards & Company's Merck position peaked at $45.8M in Q1 2024.
- 3,545 funds tracked by Wall St. Rank held Merck as of Q2 2024.
Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.